Aleš Štrancar

Title: Aleš Štrancar: Innovator in AAV Capsid Processing

Introduction

Aleš Štrancar is a notable inventor based in Ajdovšcina, Slovenia. He has made significant contributions to the field of biotechnology, particularly in the processing of adeno-associated virus (AAV) capsids. His innovative methods are paving the way for advancements in gene therapy and related applications.

Latest Patents

Aleš holds a patent for a method titled "Multimodal metal affinity processing AAV capsids." This patent describes a technique for separating full AAV capsids from empty AAV capsids in a buffered mixture. The method includes steps for removing contaminating DNA from the mixture or purified AAV capsid fraction. It can be combined with contacting the buffered mixture or the purified full AAV capsid fraction with a second substrate that bears a metal affinity ligand. This ligand is attached to the second substrate in the presence of multivalent cations, which are bound to the metal affinity ligand. The metal affinity ligand comprises two or more negatively charged carboxylic acid residues.

Career Highlights

Aleš Štrancar is currently associated with Sartorius Bia Separations D.o.o., where he applies his expertise in biotechnology. His work focuses on enhancing the efficiency and effectiveness of AAV capsid processing, which is crucial for various therapeutic applications.

Collaborations

Throughout his career, Aleš has collaborated with notable colleagues, including Maja Leskovec and Peter Stanley Gagnon. These collaborations have contributed to the advancement of research and innovation in the field of biotechnology.

Conclusion

Aleš Štrancar's contributions to the field of AAV capsid processing highlight his role as an innovator in biotechnology. His patented methods are essential for improving gene therapy techniques and advancing scientific research.